Venus Concept Share Price Today
(NASDAQ: VERO)

Name: Venus Concept Share Price Today (NASDAQ: VERO) - Venus Concept Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Venus Concept share price is $3.29 & ₹286.44 as on 6 Mar 2025, 2.30 'hrs' IST

$3.29

▲

0.14

(4.44%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Venus Concept share price in Dollar and Rupees. Guide to invest in Venus Concept stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Venus Concept, along with analyst recommendations, forecasts, and comprehensive financials.

Venus Concept share price movements

Today's Low: $2.87
Today's High: $3.44
$3.29
12.81%
Downside
Day's Volatility :16.61%
Upside
4.36%
52 Weeks Low: $2.33
52 Weeks High: $17.49
$3.29
29.18%
Downside
52 Weeks Volatility :86.68%
Upside
81.19%

Venus Concept (VERO) Returns

Period	Venus Concept Inc	Index (Russel 2000)
3 Months	-1.78%	0.0%
6 Months	-44.08%	0.0%
1 Year	-61.16%	0.0%
3 Years	-98.66%	-11.6%

Venus Concept (VERO) Key Statistics

in dollars & INR

Previous Close	$3.15
Open	$2.86
Today's High	$3.44
Today's Low	$2.8686
Market Capitalization	$2.1M
Today's Volume	$73.2K
52 Week High	$17.49
52 Week Low	$2.33
Revenue TTM	$67.2M
EBITDA	$-24.2M
Earnings Per Share (EPS)	$-90.7
Profit Margin	-74.62%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-463.54%

How to invest in Venus Concept Stock (VERO) from India?

It is very easy for Indian residents to invest directly in Venus Concept from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Venus Concept stock in both Indian Rupees (INR) and US Dollars (USD). Search for Venus Concept or VERO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Venus Concept or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Venus Concept shares which would translate to 0.265 fractional shares of Venus Concept as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Venus Concept, in just a few clicks!

Returns in Venus Concept (VERO) for Indian investors in Rupees

The Venus Concept stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Venus Concept investment value today

Current value as on today

₹43,908

Returns

₹56,092

(-56.09%)

Returns from Venus Concept Stock

₹61,157 (-61.16%)

Dollar Returns

₹5,065 (+5.06%)

Indian investors sentiment towards Venus Concept (VERO)

47%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Venus Concept Stock from India on INDmoney has increased by 47% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Venus Concept

Essex Woodlands Health Ventures
15.01%
UBS Group AG
0.78%
Vanguard Group Inc
0.45%
Geode Capital Management, LLC
0.43%
XTX Topco Ltd
0.38%
Two Sigma Investments LLC
0.16%

Analyst Recommendation on Venus Concept

Hold

0%Buy

62%Hold

37%Sell

Based on 8 Wall street analysts offering stock ratings for Venus Concept(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Venus Concept Stock (VERO)

What analysts predicted

Upside of 222.19%

Target:

$10.60

Current:

$3.29

Insights on Venus Concept Stock (Ticker Symbol: VERO)

Price Movement
In the last 6 months, VERO stock has moved down by -44.5%
Decreasing Revenue
Revenue is down for the last 7 quarters, 24.28M → 9.92M (in $), with an average decrease of 12.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -19.95M → -9.30M (in $), with an average increase of 114.5% per quarter
VERO vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 55.3% return, outperforming this stock by 116.5%
VERO vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 138.2% return, outperforming this stock by 236.9%
Price to Sales
ForVERO every $1 of sales, investors are willing to pay $0.0, whereas for Boston Scientific Corp., the investors are paying $9.2 for every $1 of sales.

VERO Venus Concept Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$22.0M	↑ 3.09%
Net Income	$-28.7M	↑ 61.0%
Net Profit Margin	-130.83%	↓ 47.05%

	FY19	Y/Y Change
Revenue	$110.4M	↑ 402.85%
Net Income	$-42.3M	↑ 47.24%
Net Profit Margin	-38.31%	↑ 92.52%

	FY20	Y/Y Change
Revenue	$78.0M	↓ 29.34%
Net Income	$-82.8M	↑ 95.81%
Net Profit Margin	-106.16%	↓ 67.85%

	FY21	Y/Y Change
Revenue	$105.6M	↑ 35.39%
Net Income	$-22.1M	↓ 73.27%
Net Profit Margin	-20.96%	↑ 85.2%

	FY22	Y/Y Change
Revenue	$99.5M	↓ 5.8%
Net Income	$-43.6M	↑ 96.85%
Net Profit Margin	-43.8%	↓ 22.84%

	FY23	Y/Y Change
Revenue	$76.4M	↓ 23.26%
Net Income	$-37.3M	↓ 14.53%
Net Profit Margin	-48.79%	↓ 4.99%

	Q1 FY23	Q/Q Change
Revenue	$20.5M	↓ 15.46%
Net Income	$-9.6M	↓ 3.19%
Net Profit Margin	-46.87%	↓ 5.94%

	Q2 FY23	Q/Q Change
Revenue	$20.1M	↓ 2.22%
Net Income	$-7.4M	↓ 23.01%
Net Profit Margin	-36.91%	↑ 9.96%

	Q3 FY23	Q/Q Change
Revenue	$17.6M	↓ 12.25%
Net Income	$-9.1M	↑ 22.39%
Net Profit Margin	-51.48%	↓ 14.57%

	Q1 FY24	Q/Q Change
Revenue	$17.5M	↓ 0.78%
Net Income	$-9.8M	↑ 8.01%
Net Profit Margin	-56.03%	↓ 4.55%

	Q2 FY24	Q/Q Change
Revenue	$16.6M	↓ 5.13%
Net Income	$-20.0M	↑ 103.71%
Net Profit Margin	-120.32%	↓ 64.29%

	Q3 FY24	Q/Q Change
Revenue	$9.9M	↓ 40.17%
Net Income	$-9.3M	↓ 53.38%
Net Profit Margin	-93.76%	↑ 26.56%

	FY18	Y/Y Change
Profit	$9.5M	↑ 3.92%

	FY19	Y/Y Change
Profit	$76.7M	↑ 706.36%

	FY20	Y/Y Change
Profit	$51.4M	↓ 32.96%

	FY21	Y/Y Change
Profit	$74.1M	↑ 44.18%

	FY22	Y/Y Change
Profit	$66.0M	↓ 10.96%

	FY23	Y/Y Change
Profit	$52.2M	↓ 20.92%

	Q1 FY23	Q/Q Change
Profit	$13.7M	↓ 13.24%

	Q2 FY23	Q/Q Change
Profit	$14.2M	↑ 3.8%

	Q3 FY23	Q/Q Change
Profit	$12.2M	↓ 14.31%

	Q1 FY24	Q/Q Change
Profit	$11.6M	↓ 4.42%

	Q2 FY24	Q/Q Change
Profit	$11.8M	↑ 1.73%

	Q3 FY24	Q/Q Change
Profit	$9.9M	↓ 16.27%

	FY18	Y/Y Change
Operating Cash Flow	$-28.7M	↑ 49.04%
Investing Cash Flow	$-8.7M	↑ 466.93%
Financing Cash Flow	$22.2M	↓ 24.28%

	FY19	Y/Y Change
Operating Cash Flow	$-39.6M	↑ 37.97%
Investing Cash Flow	$6.4M	↓ 173.74%
Financing Cash Flow	$42.2M	↑ 89.79%

	FY20	Y/Y Change
Operating Cash Flow	$-28.7M	↓ 27.64%
Investing Cash Flow	$-2.4M	↓ 137.47%
Financing Cash Flow	$49.7M	↑ 17.7%

	FY21	Y/Y Change
Operating Cash Flow	$-19.8M	↓ 30.99%
Investing Cash Flow	$-552.0K	↓ 76.92%
Financing Cash Flow	$16.8M	↓ 66.14%

	Q1 FY23	Q/Q Change
Operating Cash Flow	$-5.9M	↑ 72.82%
Investing Cash Flow	$-22.0K	↑ 0.0%
Financing Cash Flow	$803.0K	↓ 90.25%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-2.1M	↓ 63.96%
Investing Cash Flow	$-22.0K	↑ 0.0%
Financing Cash Flow	$1.9M	↑ 130.64%

Venus Concept Technicals Summary

Sell

Neutral

Buy

Venus Concept is currently in a neutral trading position according to technical analysis indicators.

Venus Concept (VERO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Venus Concept Inc	-12.01%	-44.08%	-61.16%	-98.66%	-99.66%
Medtronic Plc	3.4%	5.22%	9.95%	-11.8%	1.8%
Edwards Lifesciences Corp.	2.13%	10.35%	-17.53%	-32.76%	14.39%
Boston Scientific Corp.	1.13%	28.68%	55.31%	146.09%	207.16%
Stryker Corporation	0.84%	10.53%	11.46%	56.15%	129.21%
Abbott Laboratories	6.67%	21.76%	15.39%	15.86%	78.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Venus Concept Inc	NA	NA	NA	0.0	-4.64	-0.21	NA	15.33
Medtronic Plc	28.71	28.71	1.91	5.45	0.08	0.05	0.03	38.49
Edwards Lifesciences Corp.	31.13	31.13	5.57	2.45	0.17	0.08	NA	16.99
Boston Scientific Corp.	84.24	84.24	1.87	2.86	0.09	0.05	NA	14.76
Stryker Corporation	50.77	50.77	2.91	13.49	0.15	0.07	0.01	54.1
Abbott Laboratories	18.34	18.34	2.52	5.15	0.31	0.06	0.02	27.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Venus Concept Inc	Hold	$2.1M	-99.66%	NA	-74.62%
Medtronic Plc	Buy	$119.3B	1.8%	28.71	12.83%
Edwards Lifesciences Corp.	Buy	$42.8B	14.39%	31.13	76.75%
Boston Scientific Corp.	Buy	$152.9B	207.16%	84.24	11.07%
Stryker Corporation	Buy	$148.8B	129.21%	50.77	13.25%
Abbott Laboratories	Buy	$238.6B	78.8%	18.34	31.95%

About Venus Concept

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada.

Organization	Venus Concept
Employees	304
CEO	Mr. Rajiv Kanishka Liyanaarchchie De Silva
Industry	Health Technology

Management People of Venus Concept

Name	Title
Mr. Rajiv Kanishka Liyanaarchchie De Silva	CEO & Director
Dr. Hemanth Jacob Varghese CFA, Ph.D.	President & COO
Mr. Ross J. Portaro	EVP-Commercial Strategy, Head of Venus Hair, GM of Global Sales & Marketing
Mr. Domenic Della Penna CPA	Executive VP & CFO
Mr. Michael Mandarello	Head of Strategy & Operations, General Counsel, Corporate Secretary
Ms. Anat Kotler	Head of Marketing & Product Management
Ms. Anna Georgiadis	Chief Human Resources Officer
Ms. Melissa Kang	Chief Product Officer
Ms. Joyce Morris	Head of Sales - Canada
Mr. Ognjen Petrovic	Head of R&D, Robotics, Software

Important FAQs about investing in VERO Stock from India :

What is Venus Concept share price today?

Venus Concept share price today stands at $3.29, Open: $2.86 ; Previous Close: $3.15 ; High: $3.44 ; Low: $2.87 ; 52 Week High: $17.49 ; 52 Week Low: $2.33.

The stock opens at $2.86, after a previous close of $3.15. The stock reached a daily high of $3.44 and a low of $2.87, with a 52-week high of $17.49 and a 52-week low of $2.33.

Can Indians buy Venus Concept shares?

Yes, Indians can invest in the Venus Concept (VERO) from India.

With INDmoney, you can buy Venus Concept at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Venus Concept at zero transaction cost.

How can I buy Venus Concept shares from India?

It is very easy to buy Venus Concept from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Venus Concept (VERO) be purchased?

Yes, you can buy fractional shares of Venus Concept with INDmoney app.

What are the documents required to start investing in Venus Concept stocks?

To start investing in Venus Concept, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.